Cord Blood America Receives Commitment for $2.3 Million to Fund Its Own Stem Cell Laboratory - 500 Beiträge pro Seite
eröffnet am 14.05.09 11:06:40 von
neuester Beitrag 22.11.11 14:44:11 von
neuester Beitrag 22.11.11 14:44:11 von
Beiträge: 148
ID: 1.150.367
ID: 1.150.367
Aufrufe heute: 1
Gesamt: 20.382
Gesamt: 20.382
Aktive User: 0
ISIN: US12482D1037 · WKN: A2JM3A
0,0078
USD
+4,00 %
+0,0003 USD
Letzter Kurs 01.07.20 Nasdaq OTC
Werte aus der Branche Gesundheitswesen
Wertpapier | Kurs | Perf. % |
---|---|---|
142,07 | +93,90 | |
5,4300 | +55,81 | |
2,8800 | +51,58 | |
0,6000 | +33,63 | |
1,6320 | +30,56 |
Wertpapier | Kurs | Perf. % |
---|---|---|
3,8500 | -15,94 | |
0,9800 | -16,24 | |
1,6500 | -20,29 | |
4,1625 | -21,02 | |
2,2900 | -23,15 |
Cord Blood America Receives Commitment for $2.3 Million to Fund Its Own Stem Cell Laboratory
(PR Newswire 05.14 11:00:16)
SANTA MONICA, Calif., May 14 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today it has received a commitment for up to $2.3 million to acquire or build its own state-of-the-art laboratory for the storage of multiple stem cell products including umbilical cord blood stem cells.
"The funding is from a private, institutional investor and allows us to focus even further on our due diligence efforts that I announced last week," said Company founder and CEO Matthew Schissler. "Certain properties of the funding will be recorded as both an asset and a liability on our books." Three hundred thousand dollars of the funding has already been received by the Company to begin the lab purchase or build out, with the additional $2 million to be paid out in future installments.
"Having our own secure cryogenic stem cell bank will provide Cord Blood America with tremendous growth potential not only with our existing cord blood processing and storage business but also emerging sciences for other types of stem cells, including peripheral blood stem cell and adipose tissues," Mr. Schissler said. "We've discussed having our own lab for quite some time. Having this funding gives us the resources needed to vigorously pursue and ultimately acquire or build our own state of the art stem cell processing and storage facility."
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.
Forward-Looking Statements
Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as "anticipate," "believe," "expect," "future," "intend," "plan," and similar expressions to identify forward-looking statements. These statements including those related to the growth of the industry, new stem cell treatments, and the Company's performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.
CONTACT:
Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com
SOURCE Cord Blood America, Inc.
Contact Information:
Paul Knopick, E & E Communications, +1-949-707-5365, pknopick@eandecommunications.com, for Cord Blood America, Inc.
WebSite:
http://www.cordblood-america.com
S.PN .R2 CBAI US21839P1075 CBAI.OB CA.PN MTC.PN OTC.PN
(PR Newswire 05.14 11:00:16)
SANTA MONICA, Calif., May 14 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today it has received a commitment for up to $2.3 million to acquire or build its own state-of-the-art laboratory for the storage of multiple stem cell products including umbilical cord blood stem cells.
"The funding is from a private, institutional investor and allows us to focus even further on our due diligence efforts that I announced last week," said Company founder and CEO Matthew Schissler. "Certain properties of the funding will be recorded as both an asset and a liability on our books." Three hundred thousand dollars of the funding has already been received by the Company to begin the lab purchase or build out, with the additional $2 million to be paid out in future installments.
"Having our own secure cryogenic stem cell bank will provide Cord Blood America with tremendous growth potential not only with our existing cord blood processing and storage business but also emerging sciences for other types of stem cells, including peripheral blood stem cell and adipose tissues," Mr. Schissler said. "We've discussed having our own lab for quite some time. Having this funding gives us the resources needed to vigorously pursue and ultimately acquire or build our own state of the art stem cell processing and storage facility."
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.
Forward-Looking Statements
Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as "anticipate," "believe," "expect," "future," "intend," "plan," and similar expressions to identify forward-looking statements. These statements including those related to the growth of the industry, new stem cell treatments, and the Company's performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.
CONTACT:
Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com
SOURCE Cord Blood America, Inc.
Contact Information:
Paul Knopick, E & E Communications, +1-949-707-5365, pknopick@eandecommunications.com, for Cord Blood America, Inc.
WebSite:
http://www.cordblood-america.com
S.PN .R2 CBAI US21839P1075 CBAI.OB CA.PN MTC.PN OTC.PN
Time MMID Size Bid
08:02 Close
Archipelago Trading Services, Inc.
OTCBB TRADING
312-442-7700
NASDAQ TRADING
312-960-1318
ARCA 99900 0.0092
08:02 Close
Archipelago Trading Services, Inc.
OTCBB TRADING
312-442-7700
NASDAQ TRADING
312-960-1318
ARCA 99900 0.0092
geht ja
0.50 14000 Close
Archipelago Trading Services, Inc.
NASDAQ TRADING
312-960-1318
OTCBB TRADING
312-442-7700
ARCA 12:45
Archipelago Trading Services, Inc.
NASDAQ TRADING
312-960-1318
OTCBB TRADING
312-442-7700
ARCA 12:45
..
na, es geht doch
schönes W
was ist schon der Cent
wenn es drei werden können
wenn es drei werden können
mal schauen, was um 20 Uhr geht
heute den Cent
Hi gerdas
was bedeutet die News die du um 23Uhr gepostet hast ?
mein englisch reicht da leider nicht aus
was bedeutet die News die du um 23Uhr gepostet hast ?
mein englisch reicht da leider nicht aus
Antwort auf Beitrag Nr.: 38.119.700 von Zockerl69 am 05.10.09 23:21:03Das hat nichts zu sagen
ich vermute, dass einige überhaupt nicht wissen
um was es hier geht
es ist lediglich der Link zur HP
http://www.cordblood-america.com/News/Latest-Press-Releases-…
hier geht es um viel mehr, als nur das Patent
wenn es eine Zukunft dieser Art von Aktien verbunden mit der (Änderung der Gesetzeslage-USA)geben wird,
dann sollte man hier verweilen
ich vermute, dass einige überhaupt nicht wissen
um was es hier geht
es ist lediglich der Link zur HP
http://www.cordblood-america.com/News/Latest-Press-Releases-…
hier geht es um viel mehr, als nur das Patent
wenn es eine Zukunft dieser Art von Aktien verbunden mit der (Änderung der Gesetzeslage-USA)geben wird,
dann sollte man hier verweilen
bin hier mit 2000 euro drinne !
und aktuell 85% im Plus
ja solang komme ich ins nachdenken, bin informiert ueber die aktie
und werde vorerst nicht verkaufen aber bei weiteren anstiegen einen grossen teil rausnehmen und den rest laufenlassen
und aktuell 85% im Plus
ja solang komme ich ins nachdenken, bin informiert ueber die aktie
und werde vorerst nicht verkaufen aber bei weiteren anstiegen einen grossen teil rausnehmen und den rest laufenlassen
Antwort auf Beitrag Nr.: 38.119.734 von Zockerl69 am 05.10.09 23:38:29wenn du auf Nummer sicher gehen möchtest
ist das ok
ist das ok
Antwort auf Beitrag Nr.: 38.119.734 von Zockerl69 am 05.10.09 23:38:29jetzt sind es keine 85% mehr. Jetzt fragst du dich retten was zu retten ist oder nachkaufen, weil du ja überzeugt bist
Letzteres ist auch eine Form von Stolz und kann richtig teuer werden. Nach der Charttechnik solltest du nicht über 0,7 Cent limitieren, wenn schon....
Viel Glück
Letzteres ist auch eine Form von Stolz und kann richtig teuer werden. Nach der Charttechnik solltest du nicht über 0,7 Cent limitieren, wenn schon....
Viel Glück
Antwort auf Beitrag Nr.: 38.119.718 von gerdass am 05.10.09 23:30:40aber man muss nicht der Mann der ersten Stunde sein und durchhalten. Man darf zwischendurch gerne mal abspringen und wieder aufspringen. Ist manchmal gesünder. Ich bin bei 0,9 Cent raus und freue mich jetzt darüber. Unter 0,7 wird es wieder interessant, aber einsteigen werde ich wohl dieses Jahr nicht mehr.
Ich hab sie auf die Watchlist verbannt
Ich hab sie auf die Watchlist verbannt
Antwort auf Beitrag Nr.: 38.125.298 von dottore am 06.10.09 17:48:45dann schau mal zu
was wir gleich machen
was wir gleich machen
Antwort auf Beitrag Nr.: 38.125.279 von dottore am 06.10.09 17:46:00den Cent werden wir im SK durchbrechen
wenn schon in dem bereich und spekulativ, dann KOOL
ein W
Antwort auf Beitrag Nr.: 38.125.983 von gerdass am 06.10.09 19:02:10
Antwort auf Beitrag Nr.: 38.126.035 von gerdass am 06.10.09 19:09:05Nun ist es ein M
Antwort auf Beitrag Nr.: 38.126.133 von Scania01 am 06.10.09 19:17:17
Antwort auf Beitrag Nr.: 38.126.133 von Scania01 am 06.10.09 19:17:17kommt gleich
Antwort auf Beitrag Nr.: 38.126.046 von ebooker am 06.10.09 19:09:54wenn ich einen Balken setze
laufen sie gleich alle hinterher
laufen sie gleich alle hinterher
After Hours: $ 0.0088 0.0002 (+2.33%) Volume: 45.0 k 16:00 EDT 06.10.2009
close 52 Week Information
52 Week High
January 29,2009
Close: 0.025 52 Week Low
October 21,2008
Close: 0.001
close 52 Week Information
52 Week High
January 29,2009
Close: 0.025 52 Week Low
October 21,2008
Close: 0.001
Cord Blood America Announces Debt Reduction Tally: $8.7 Million in 2009; $3.7 Million in Third Quarter
LAS VEGAS, Oct 07, 2009 /PRNewswire-FirstCall via COMTEX/ -- Cord Blood America, Inc. /quotes/comstock/11k!cbai (CBAI 0.01, 0.00, -12.24%) , the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has reduced its debt by a total of $3.7 million in the third quarter of 2009. Total debt eliminated in 2009 is $8.7 million.
"We recently announced the retirements of four separate notes and wanted to give our investors a concise tally for the quarter. We have emphasized to our investors throughout the year that debt reduction is one of the pillars needed for our ongoing and future success. We are pleased that we have been able to consistently announce debt reductions in 2009. We urge our shareholders to continue to follow our progress as we strengthen the Company and its balance sheet for the long term," said Matthew Schissler, co-founder and CEO.
Cord Blood America also announced this year that it retired $2.53 million of long-term debt with an opportunity fund and that it received a $2.3 million commitment to finance its stem cell laboratory and headquarters in Las Vegas.
About Cord Blood America
Cord Blood America /quotes/comstock/11k!cbai (CBAI 0.01, 0.00, -12.24%) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. /quotes/comstock/11k!cbai (CBAI 0.01, 0.00, -12.24%) , visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.
CONTACT:
Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com
SOURCE Cord Blood America, Inc.
http://www.cordblood-america.com
Copyright (C) 2009 PR Newswire. All rights reserved
LAS VEGAS, Oct 07, 2009 /PRNewswire-FirstCall via COMTEX/ -- Cord Blood America, Inc. /quotes/comstock/11k!cbai (CBAI 0.01, 0.00, -12.24%) , the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has reduced its debt by a total of $3.7 million in the third quarter of 2009. Total debt eliminated in 2009 is $8.7 million.
"We recently announced the retirements of four separate notes and wanted to give our investors a concise tally for the quarter. We have emphasized to our investors throughout the year that debt reduction is one of the pillars needed for our ongoing and future success. We are pleased that we have been able to consistently announce debt reductions in 2009. We urge our shareholders to continue to follow our progress as we strengthen the Company and its balance sheet for the long term," said Matthew Schissler, co-founder and CEO.
Cord Blood America also announced this year that it retired $2.53 million of long-term debt with an opportunity fund and that it received a $2.3 million commitment to finance its stem cell laboratory and headquarters in Las Vegas.
About Cord Blood America
Cord Blood America /quotes/comstock/11k!cbai (CBAI 0.01, 0.00, -12.24%) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. /quotes/comstock/11k!cbai (CBAI 0.01, 0.00, -12.24%) , visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.
CONTACT:
Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com
SOURCE Cord Blood America, Inc.
http://www.cordblood-america.com
Copyright (C) 2009 PR Newswire. All rights reserved
Bid
08:47 Close
Vandham Securities Corp.
WOODCLIFF LAKE, NJ
(201) 782.3310
WOODCLIFF LAKE, NJ
888.356.2179
VNDM 5000 0.0092 ↑
08:47 Close
Vandham Securities Corp.
WOODCLIFF LAKE, NJ
(201) 782.3310
WOODCLIFF LAKE, NJ
888.356.2179
VNDM 5000 0.0092 ↑
wer verkauft
hat verloren ?
hat verloren ?
Was ist das
Antwort auf Beitrag Nr.: 38.141.629 von Scania01 am 08.10.09 17:24:05Supergau
Sollte es unter die 0,008 USD gehen bin ich sofort raus aus der Aktie.
Antwort auf Beitrag Nr.: 38.141.750 von D2Chris am 08.10.09 17:34:57ich werde erst unter 8 kaufen
Mehr geht nicht
http://quote.barchart.com/texpert.asp?sym=cbai&code=BSTK<…
http://quote.barchart.com/texpert.asp?sym=cbai&code=BSTK<…
Antwort auf Beitrag Nr.: 38.141.629 von Scania01 am 08.10.09 17:24:05Ist das jetzt das letzte aufbäumen gewesen:
[/img]
Neues Interview CBAI auf Facebook
Here are the highlights I got from the interview
http://www.facebook.com/CordBloodOfAmerica?ref=ts
Straight from Matt Schissler's mouth
- Debt likely to be retired by 12/31/2009 or early 2010 at latest.
- Reduced debt by 9.6 million since 1/1/2009
- Las Vegas lab to be fully operational by or before 1/31/2010.
- 2010 looking to diversify revenue streams by obtaining contracts from other companies to store their stem cells and other biological products.
- 2010 reducing costs of goods sold to increase revenue.
- CEO points out that stock price has risen 4x with the dilution (since the beginning of this year), and that the debts are almost paid off which will likely end the dilution.
Main Points:
2009
Debt Reduction, Organic Growth, and acquisition
2010
Organic growth, acquisition, and diversification of revenue streams
Glück auf!
Here are the highlights I got from the interview
http://www.facebook.com/CordBloodOfAmerica?ref=ts
Straight from Matt Schissler's mouth
- Debt likely to be retired by 12/31/2009 or early 2010 at latest.
- Reduced debt by 9.6 million since 1/1/2009
- Las Vegas lab to be fully operational by or before 1/31/2010.
- 2010 looking to diversify revenue streams by obtaining contracts from other companies to store their stem cells and other biological products.
- 2010 reducing costs of goods sold to increase revenue.
- CEO points out that stock price has risen 4x with the dilution (since the beginning of this year), and that the debts are almost paid off which will likely end the dilution.
Main Points:
2009
Debt Reduction, Organic Growth, and acquisition
2010
Organic growth, acquisition, and diversification of revenue streams
Glück auf!
SIMPLE REASONS THIS STOCK WILL GO UP!
Just in case you are worried about your sub-penny stock investment. Please consider the following reasons to note why this stock will eventually go up.
1. CBAI received $7.5 million pledge from Optimus Capital Partners to be paid in stages. The first installment helped get the Las Vegas Lab underway and the rest of the money will come ONLY when the company meets certain financial requirements. So its in CBAI's benefit to make some financial progress soon to get the next installment.(Which means it will go up). Do you not see this train coming before the end of the year?
2. CBAI also received $4 million investment from Tangiers Investors but has ONLY received $325k through the end of the second quarter. Do you not forsee CBAI getting more money by the beginning of next year?
3.Mr. Obama has pleded big money to stem cell companies---that should be infused to those companies withing the next 6 months. That's Mr. Obama's godchild (stem cell research)-he will do all it takes to make huge progress with that before the end of his term.. Ride the wave!
4. Common sense should tell you that if this company was over a dollar (many investors that believed obviously) less than a year ago---with no progress, guess where it will be within the next year--with all the progress in store-OVER $2.
5. Simple math should apply.. This stock is less than a penny....so if it gets to a dollar at some point during your life time----that should make you what percent? If you can't figure that out you should stick to investing in stocks like Walmart and Apple.
Enough said.
GLTA... This is JMHO.
http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks…
Just in case you are worried about your sub-penny stock investment. Please consider the following reasons to note why this stock will eventually go up.
1. CBAI received $7.5 million pledge from Optimus Capital Partners to be paid in stages. The first installment helped get the Las Vegas Lab underway and the rest of the money will come ONLY when the company meets certain financial requirements. So its in CBAI's benefit to make some financial progress soon to get the next installment.(Which means it will go up). Do you not see this train coming before the end of the year?
2. CBAI also received $4 million investment from Tangiers Investors but has ONLY received $325k through the end of the second quarter. Do you not forsee CBAI getting more money by the beginning of next year?
3.Mr. Obama has pleded big money to stem cell companies---that should be infused to those companies withing the next 6 months. That's Mr. Obama's godchild (stem cell research)-he will do all it takes to make huge progress with that before the end of his term.. Ride the wave!
4. Common sense should tell you that if this company was over a dollar (many investors that believed obviously) less than a year ago---with no progress, guess where it will be within the next year--with all the progress in store-OVER $2.
5. Simple math should apply.. This stock is less than a penny....so if it gets to a dollar at some point during your life time----that should make you what percent? If you can't figure that out you should stick to investing in stocks like Walmart and Apple.
Enough said.
GLTA... This is JMHO.
http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks…
Antwort auf Beitrag Nr.: 38.293.904 von itsSHOWTIME am 30.10.09 21:34:32Gebt euch nicht so viel Mühe, der Kurs spricht eine Eindeutige Sprache.
Antwort auf Beitrag Nr.: 38.298.190 von Skrollein am 01.11.09 17:42:57Meinst du damit die Richtung?
!
Dieser Beitrag wurde moderiert. Grund: Fäkalsprache!
Dieser Beitrag wurde moderiert. Grund: themenfremder Inhalt
Antwort auf Beitrag Nr.: 38.320.341 von Scania01 am 04.11.09 18:03:01mal wieder was los?? gerade 10 Mio übern Tisch
naja, geht mal wieder up, wohl wieder Meldung vom Schuldenstand
heute gleich wieder +25% ist doch seltsam aber schön.
Konnte noch keine News finden! Rennen wohl alle der Herde nach.
Antwort auf Beitrag Nr.: 38.497.494 von Digedanium am 02.12.09 20:03:05Erst einmal abwarten und Tee trinken.
Eine Schwalbe macht noch keinen Sommer.
Eine Schwalbe macht noch keinen Sommer.
Antwort auf Beitrag Nr.: 38.497.518 von Scania01 am 02.12.09 20:05:49aber viele schon eher
ich habe weder Bedenken, dass wir hier eine Luftnummer haben, noch dass hier binnen Tagen -entweder jetzt oder später- einen schönen Up-jump erleben.
ich habe weder Bedenken, dass wir hier eine Luftnummer haben, noch dass hier binnen Tagen -entweder jetzt oder später- einen schönen Up-jump erleben.
Antwort auf Beitrag Nr.: 38.497.672 von Digedanium am 02.12.09 20:24:45schau mer mal
seit gestern Freigabe der Stammzellenforschung offiziell
- müsste auch der Grund für Anstieg sein.
- müsste auch der Grund für Anstieg sein.
Antwort auf Beitrag Nr.: 38.499.442 von Digedanium am 03.12.09 08:27:09siehe Nachbar Thread...hatte es gestern eingestellt....nur hat es keiner bemerkt...ich schon...und noch gunstig aufgestockt...aber erst mal sehen was der Kurs heute macht....Cord ist launisch
geht hier noch was
sagte ich doch
hier geht was
hier geht was
da geht doch gleich was
Antwort auf Beitrag Nr.: 38.547.244 von itsSHOWTIME am 10.12.09 21:11:15Cord Blood America (CBAI.OB) to Open "State of the Art" Cryogenic Lab in Las Vegas
gestern: ein starkes handelsvolumen von weit über 1 mio. usd !!!!
und das bei steigendem kurs !!!!
EINFACH NUR GREAT
IT´S JUST THE BEGINNING
HEUTE NACHMITTAG UM 15.30 UHR: itsSHOWTIME
und das bei steigendem kurs !!!!
EINFACH NUR GREAT
IT´S JUST THE BEGINNING
HEUTE NACHMITTAG UM 15.30 UHR: itsSHOWTIME
Antwort auf Beitrag Nr.: 38.548.811 von itsSHOWTIME am 11.12.09 08:55:50und im januar 2010 die neueröffnung ,da kommt noch fantasie rein jetztkaufen und laufen lassen ,nur meine meinung , keine kauf verkauf empfehlung
Antwort auf Beitrag Nr.: 38.548.913 von CLICKTO am 11.12.09 09:13:13keine kaufempfehlung ??
doch: du bist schuld, wenn der aktienkurs nicht up geht !!
doch: du bist schuld, wenn der aktienkurs nicht up geht !!
Antwort auf Beitrag Nr.: 38.548.979 von itsSHOWTIME am 11.12.09 09:23:39ich will doch hinterher nicht der buhmann sein , ich habe gekauft ( schon vor wochen )und denke das es eine gutes invest ist , jeder soll für sich entscheiden und nich wegen irgendwelchen postings auf wo ,
Antwort auf Beitrag Nr.: 38.548.811 von itsSHOWTIME am 11.12.09 08:55:50Yes
Article just out on CBAI - Target $18 in 5 years!!!!
http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks…
http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks…
Antwort auf Beitrag Nr.: 38.562.702 von itsSHOWTIME am 14.12.09 14:05:43die amis neigen mal wieder zu extremen übertreibungen !!!!!
itsSHOWTIME
Antwort auf Beitrag Nr.: 38.566.244 von gerdass am 14.12.09 21:42:35YES
+
IT`S JUST THE BEGINNING !!!
+
IT`S JUST THE BEGINNING !!!
Antwort auf Beitrag Nr.: 38.566.333 von itsSHOWTIME am 14.12.09 21:56:06wer weiß das schon
Antwort auf Beitrag Nr.: 38.566.368 von gerdass am 14.12.09 22:00:17gefällt mir echt gut !!
Antwort auf Beitrag Nr.: 38.566.362 von gerdass am 14.12.09 21:59:34heutiges handelsvolumen > 2 mio usd.
das waren nicht nur die kleinen wo-zocker !!
das waren nicht nur die kleinen wo-zocker !!
Antwort auf Beitrag Nr.: 38.562.789 von itsSHOWTIME am 14.12.09 14:19:59bis zur Eröffnung im Januar scheint etwas Zunder gelegt zu werden.
"die Amis mögen es bei Centzocks, wenn durch stetigen Newsflow der Nachweis erbracht wird, hier läge keine Scheinfirma vor" . Sehr interessant!
Das dürfte uns weiter auf die Sprünge helfen. Mein nächstes Ziel bleibt 0,018 €!
"die Amis mögen es bei Centzocks, wenn durch stetigen Newsflow der Nachweis erbracht wird, hier läge keine Scheinfirma vor" . Sehr interessant!
Das dürfte uns weiter auf die Sprünge helfen. Mein nächstes Ziel bleibt 0,018 €!
Antwort auf Beitrag Nr.: 38.567.527 von Digedanium am 15.12.09 09:10:45Was haltet ihr von Übernahme?
Ich meine Vita 34 ist doch noch zur Zeit ein Schnäpchen.
Ich meine Vita 34 ist doch noch zur Zeit ein Schnäpchen.
wer soll wen übernehmen? Vita36 übernimmt CBAT oder umgekehrt ?
Antwort auf Beitrag Nr.: 38.636.659 von fuerza_hercuela am 28.12.09 15:54:41Na wer von beiden ist denn am günstigsten?
... der gestrige handelstag:
2551 kursfeststellungen bei einem handelsvolumen von 5,37 mio. usd !!!!
Antwort auf Beitrag Nr.: 38.645.944 von itsSHOWTIME am 30.12.09 10:47:40nicht unschlecht
Antwort auf Beitrag Nr.: 38.663.644 von itsSHOWTIME am 04.01.10 20:47:02http://www.zeit.de/newsticker/2009/12/27/iptc-bdt-20091227-4…
Antwort auf Beitrag Nr.: 38.671.338 von itsSHOWTIME am 05.01.10 21:12:01
damit das posting 2914 nicht so schnell unter geht:
http://www.wallstreet-online.de/diskussion/1146013-2911-2920…
http://www.wallstreet-online.de/diskussion/1146013-2911-2920…
kann nicht schaden
wenn man auch mal etwas raußnimmt
wenn man auch mal etwas raußnimmt
einfach nur great:
http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks…
CBAI CEO states his company will become Cash Flow Positive for the First Time in its history... 1-Feb-10 06:33 pm 2009 Institutional Investor $2.3 million for the lab:
\"The funding is from a private, institutional investor and allows us
to focus even further on our due diligence efforts that I announced
last week,\" said Company founder and CEO Matthew Schissler. \"Certain
properties of the funding will be recorded as both an asset and a
liability on our books.\" Three hundred thousand dollars of the funding
has already been received by the Company to begin the lab purchase or
build out, with the additional $2 million to be paid out in future
installments.
http://gaskinsco.com/linkto-cbai.shtml
----------------------------------------------------- --
2009 Matt Schissler statement \"Cash Flow Positive\":
What Cord Blood America does not intend to do is to spend money on
costly, endless research and development. Also, it does not need to
discover something revolutionary… that’s been done already. The
Company has certainly received some help from the U.S.\'s top
politician. On March 9th, 2009, an executive order was signed by
President Obama eliminating restrictions on Federal funding of stem
cell research which signalled a significant move forward for the
entire stem cell sector.
\"Scientists are confident that stem cell research will lead to
fundamental improvements in the treatment of heart disease, diabetes,
Parkinson\'s disease and other of our most difficult to treat
illnesses,\" said Matthew Schissler, Cord Blood America Founder and
CEO. \"Stem cells are believed capable of becoming any tissue in the
body, which could lead to treatments for illnesses currently
impossible to cure.\"
\"The Company has reduced it\'s long term debt by over $2.5 Million in
2009 and is on track to become cash flow positive for the first time
in its history...\"
With the Company focusing strongly on becoming cash flow positive in
\'09 along with their aggressive expansion through internal growth
coupled with strategic acquisitions and the new policy change done at
the White House level, CBAI is a Company worth taking a closer look
into as it strives to be the leader in educating about the advantages
of these cord blood banking services and then to be the top performer
in signing new families to utilize its services.
http://gaskinsco.com/linkto-cbai.shtml
http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks…
CBAI CEO states his company will become Cash Flow Positive for the First Time in its history... 1-Feb-10 06:33 pm 2009 Institutional Investor $2.3 million for the lab:
\"The funding is from a private, institutional investor and allows us
to focus even further on our due diligence efforts that I announced
last week,\" said Company founder and CEO Matthew Schissler. \"Certain
properties of the funding will be recorded as both an asset and a
liability on our books.\" Three hundred thousand dollars of the funding
has already been received by the Company to begin the lab purchase or
build out, with the additional $2 million to be paid out in future
installments.
http://gaskinsco.com/linkto-cbai.shtml
----------------------------------------------------- --
2009 Matt Schissler statement \"Cash Flow Positive\":
What Cord Blood America does not intend to do is to spend money on
costly, endless research and development. Also, it does not need to
discover something revolutionary… that’s been done already. The
Company has certainly received some help from the U.S.\'s top
politician. On March 9th, 2009, an executive order was signed by
President Obama eliminating restrictions on Federal funding of stem
cell research which signalled a significant move forward for the
entire stem cell sector.
\"Scientists are confident that stem cell research will lead to
fundamental improvements in the treatment of heart disease, diabetes,
Parkinson\'s disease and other of our most difficult to treat
illnesses,\" said Matthew Schissler, Cord Blood America Founder and
CEO. \"Stem cells are believed capable of becoming any tissue in the
body, which could lead to treatments for illnesses currently
impossible to cure.\"
\"The Company has reduced it\'s long term debt by over $2.5 Million in
2009 and is on track to become cash flow positive for the first time
in its history...\"
With the Company focusing strongly on becoming cash flow positive in
\'09 along with their aggressive expansion through internal growth
coupled with strategic acquisitions and the new policy change done at
the White House level, CBAI is a Company worth taking a closer look
into as it strives to be the leader in educating about the advantages
of these cord blood banking services and then to be the top performer
in signing new families to utilize its services.
http://gaskinsco.com/linkto-cbai.shtml
Antwort auf Beitrag Nr.: 38.915.456 von itsSHOWTIME am 10.02.10 08:27:58Allen ein schönes Wochenende!
http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks…
(((Here\'s the REAL deal--All You Need to Know))) 19-Jan-10 10:09 pm **-- New $3 million financing focused on avoiding dilution and being investor-friendly as CBAI puts in place its business strategy for success in 2010.
Grand Opening of its Las Vegas corporate office and laboratory beginning at Noon to 5 p.m. on Friday, January 22, 2010.
**-- Contracted with The Center for Stem Cell Awareness to re-sell its stem cell collection and storage services.
**-- Retired a $1.35 million note which had been provided by JMJ Financial in May of 2009.
**-- Voracious Appetite for Growth, Expansion and Acquisitions
**-- Signed a Letter of Intent to process and store cord blood specimens for BioCells, Inc., headquartered in Argentina, and its affiliates in Peru, Colombia, Bolivia, Panama and Puerto Rico.
**-- 2009 Total debt eliminated for the year tops $10 million
**-- One of the Largest Cryogenic Storage Labs in U.S.
**-- Cord Blood America Announces Preferred Pricing for Blue Cross of Northeastern Pennsylvania Members
**-- Signed an agreement with a marketing affiliate for expansion of its services into Panama, Bermuda and Aruba.
**-- Begun due diligence for sales operation expansion into the European Union, specifically Belgium and Italy.
**-- No more Dilution, profitability, acquisitions = larger market share and increased share valuations...This will not remain a sub .10 penny stock much longer imo....ITS COMING!!!
(((Here\'s the REAL deal--All You Need to Know))) 19-Jan-10 10:09 pm **-- New $3 million financing focused on avoiding dilution and being investor-friendly as CBAI puts in place its business strategy for success in 2010.
Grand Opening of its Las Vegas corporate office and laboratory beginning at Noon to 5 p.m. on Friday, January 22, 2010.
**-- Contracted with The Center for Stem Cell Awareness to re-sell its stem cell collection and storage services.
**-- Retired a $1.35 million note which had been provided by JMJ Financial in May of 2009.
**-- Voracious Appetite for Growth, Expansion and Acquisitions
**-- Signed a Letter of Intent to process and store cord blood specimens for BioCells, Inc., headquartered in Argentina, and its affiliates in Peru, Colombia, Bolivia, Panama and Puerto Rico.
**-- 2009 Total debt eliminated for the year tops $10 million
**-- One of the Largest Cryogenic Storage Labs in U.S.
**-- Cord Blood America Announces Preferred Pricing for Blue Cross of Northeastern Pennsylvania Members
**-- Signed an agreement with a marketing affiliate for expansion of its services into Panama, Bermuda and Aruba.
**-- Begun due diligence for sales operation expansion into the European Union, specifically Belgium and Italy.
**-- No more Dilution, profitability, acquisitions = larger market share and increased share valuations...This will not remain a sub .10 penny stock much longer imo....ITS COMING!!!
http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks…
Next News CBAI NO DEBT, Got to Love it! 16-Mar-10 04:33 pm How can you sit there and bash this company when its only positive building by this company.
New facility
Major contracts and more to come
State of Art processing of Cord Blood
State of Art cord blood tracking system
New doctors joining the Board.
Employee #s going from 25 to 75
Already taking about another facility build up
Taking over another major cord blood or stem cell company
Debt Free
No longer issuing shares.
Man you have to be on crack not to like the future of this company, plain and simple!
Next News CBAI NO DEBT, Got to Love it! 16-Mar-10 04:33 pm How can you sit there and bash this company when its only positive building by this company.
New facility
Major contracts and more to come
State of Art processing of Cord Blood
State of Art cord blood tracking system
New doctors joining the Board.
Employee #s going from 25 to 75
Already taking about another facility build up
Taking over another major cord blood or stem cell company
Debt Free
No longer issuing shares.
Man you have to be on crack not to like the future of this company, plain and simple!
!!NEWS!!
und ich glaube keine schlechten
und ich glaube keine schlechten
Hallo,
steht irgendwas neues im Programm? Kann auf der Homepage nichts finden
steht irgendwas neues im Programm? Kann auf der Homepage nichts finden
klares Kaufsignal
der Hammer
LAS VEGAS and HAMBURG, Germany, June 23
LAS VEGAS and HAMBURG, Germany, June 23 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI) (www.cordblood-america.com) is pleased to announce that Thomas Kolzau, Hamburg, Germany, an executive with a strong record of success in the medical, life sciences and bio/pharma industries, has been appointed Managing Director of Cord Blood America's 51 percent owned stellacure GmbH, the third largest cord blood banking service in Germany.
Mr. Kolzau previously served as CEO for a consulting firm which advised on the German health care system and the life sciences industry in that European nation. He served as Head of Sales & Business Development for IBP AG, a leading company in the field of assessment, development, and application of patent-based technologies. With a managed asset volume of over 200 million euros, IBP AG is the market leader in the field of technology development funds.
Mr. Kolzau earned a diploma as a biologist at UKE Hamburg University. He has done doctoral and post doctoral studies in oncology and innovative drug development. He has also served as an executive with life sciences and microarray systems companies as well as companies in the bio/pharma industry.
"We are pleased that such a successful, talented executive is joining us at Cord Blood America. We envision our new German facility as the hub to expand into the rest of Europe, where saving umbilical cord blood stem cells is becoming increasingly popular," said Matthew Schissler, co-founder and CEO.
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.
CONTACT:
Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com
LAS VEGAS and HAMBURG, Germany, June 23
LAS VEGAS and HAMBURG, Germany, June 23 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI) (www.cordblood-america.com) is pleased to announce that Thomas Kolzau, Hamburg, Germany, an executive with a strong record of success in the medical, life sciences and bio/pharma industries, has been appointed Managing Director of Cord Blood America's 51 percent owned stellacure GmbH, the third largest cord blood banking service in Germany.
Mr. Kolzau previously served as CEO for a consulting firm which advised on the German health care system and the life sciences industry in that European nation. He served as Head of Sales & Business Development for IBP AG, a leading company in the field of assessment, development, and application of patent-based technologies. With a managed asset volume of over 200 million euros, IBP AG is the market leader in the field of technology development funds.
Mr. Kolzau earned a diploma as a biologist at UKE Hamburg University. He has done doctoral and post doctoral studies in oncology and innovative drug development. He has also served as an executive with life sciences and microarray systems companies as well as companies in the bio/pharma industry.
"We are pleased that such a successful, talented executive is joining us at Cord Blood America. We envision our new German facility as the hub to expand into the rest of Europe, where saving umbilical cord blood stem cells is becoming increasingly popular," said Matthew Schissler, co-founder and CEO.
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.
CONTACT:
Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com
Antwort auf Beitrag Nr.: 39.754.157 von gerdass am 29.06.10 21:40:34????
Antwort auf Beitrag Nr.: 39.754.307 von DerKoepenicker am 29.06.10 22:01:32 Ask Size MMID Time
0.0055 5000 UBSS 15:27
↑ 0.006 5000 HDSN 10:06
↓ 0.0075 5000 BTIG 07:40
0.0085 5000 PERT 15:00
0.01 5000 VFIN 12:52
↓ 0.0115 5000 LAMP 08:49
0.019 5000 LABS 07:30
0.03 5000 GARC 07:30
0.10 5000 BNCH 07:30
0.10 5000 LFCM 07:30
0.519 2500 VERT 07:30
10.00 500 JSUP 07:30
schaut doch gut aus
0.0055 5000 UBSS 15:27
↑ 0.006 5000 HDSN 10:06
↓ 0.0075 5000 BTIG 07:40
0.0085 5000 PERT 15:00
0.01 5000 VFIN 12:52
↓ 0.0115 5000 LAMP 08:49
0.019 5000 LABS 07:30
0.03 5000 GARC 07:30
0.10 5000 BNCH 07:30
0.10 5000 LFCM 07:30
0.519 2500 VERT 07:30
10.00 500 JSUP 07:30
schaut doch gut aus
!
Dieser Beitrag wurde moderiert. Grund: Spammposting
also
5 mille hol ich mir noch
5 mille hol ich mir noch
Antwort auf Beitrag Nr.: 39.758.769 von gerdass am 30.06.10 17:28:13Ich hab 2,3 Millionen...
Ich hoffe das Ding kostet bald nen Euro..
Ich hoffe das Ding kostet bald nen Euro..
Antwort auf Beitrag Nr.: 39.759.478 von DerKoepenicker am 30.06.10 19:18:05wer Geduld hat
warum nicht
warum nicht
............
Antwort auf Beitrag Nr.: 39.763.143 von gerdass am 01.07.10 13:07:35 ?
Antwort auf Beitrag Nr.: 39.763.536 von DerKoepenicker am 01.07.10 14:08:52das war der Anfang
Bei 5 MRd. Aktien ist ein Kurs von 1 Euro eher unwahrscheinlich, oder?
diese Ruhe hier
was für volldeppen kaufen in D
Antwort auf Beitrag Nr.: 40.033.082 von gerdass am 24.08.10 02:30:10niederlage für obama. stammzellenforschung durch behörde gestoppt.
was hat das für eine einfluss auf cord blood?
was hat das für eine einfluss auf cord blood?
Antwort auf Beitrag Nr.: 40.061.018 von commodityleviathan am 28.08.10 12:35:43s. hauptthread - z.b. beitrag 6300 oder 6308
Antwort auf Beitrag Nr.: 40.067.783 von itsSHOWTIME am 30.08.10 15:29:51Hallo zusammen, da war das erste Mal seit Monaten bei den Amis mal wieder richtig was los in Sachen CBAI und hier hat es keiner mitbekommen. Es gab mal wieder eine Verlautbarung letzten Montag, aber diese könnte wohl in der Tat sehr vielversprechend für den Wert der Aktie sein. Eine Vereinbarung mit der National Association Representing U.S. Health Insurance Plans könnte der Durchbruch für CBAI in den USA sein. Zumindest hat das Volumen deutlichst angezogen. Mal sehen, was nächste Woche bringt.
http://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?F…
How Can I Vote Without Attending the Special Meeting?
There are three convenient methods for registered stockholders to direct their vote by proxy without attending the Special Meeting:
● Submit your proxy by Internet. You can submit your proxy via the Internet. The website address for Internet voting is provided on your Cord Blood Notice or proxy card. You will need to use the control number appearing on your Cord Blood Notice or proxy card to vote via the Internet. You can use the Internet to transmit your voting instructions up until 11:59 P.M. Eastern Time on April 20, 2011. Internet voting is available 24 hours a day. If you submit your proxy via the Internet you do NOT need to submit a proxy by telephone or return a proxy card.
● Vote by Telephone. You may also be able to submit your proxy by telephone by calling the toll-free telephone number provided on your Cord Blood proxy card. You will need to use the control number appearing on your Cord Blood proxy card to submit your proxy by telephone. You may transmit your voting instructions from any touch-tone telephone up until 11:59 P.M. Eastern Time on April 20, 2011. Telephone voting is available 24 hours a day. If you submit your proxyby telephone you do NOT need to submit a proxy over the Internet or return a proxy card.
● Vote by Mail. You can submit your proxy by marking, dating and signing the enclosed Proxy Card Form, and returning it in the postage-paid envelope provided. Please promptly mail your proxy card to ensure that it is received prior to the closing of the polls at the Special Meeting.
Proxies should not be sent by the stockholder to the Company, but please use pre-addressed, postage-paid envelope is provided for this purpose.
If you are a beneficial owner, or you hold your shares in "street name," please check your voting instruction card or contact your bank, broker or nominee to determine whether you will be able to vote by Internet or telephone.
EXHIBIT A
PROPOSAL 1:
TO REVERSE SPLIT THE OUTSTANDING COMMON STOCK OF CORD BLOOD AMERICA, INC. ON THE BASIS OF ONE NEW POST SPLIT COMMON SHARE FOR EACH 100 CURRENTLY OUTSTANDING COMMON SHARES
Pursuant to the provisions of Section 607.1006, Florida Statutes, Cord Blood America, Inc., a Florida corporation (the “Corporation”), adopts the following articles of amendment to its Amended and Restated Articles of Incorporation:
The Amended and Restated Articles of Incorporation of the Corporation are hereby amended as follows:
“Upon the filing and effectiveness of this Amendment to the Amended and Restated Articles of Incorporation with the Florida Secretary of State, every ONE HUNDRED ( 100 ) outstanding shares of Common Stock shall be automatically combined into one (1) share of Common Stock.”
PROPOSAL 2:
TO AMENDMENT THE AMENDED AND RESTATE ARTICLES OF CORD BLOOD AMERICA, INC., TO FIX THE AUTHORIZED CAPITAL STOCK AT 255,000,000 CAPITAL SHARES
Pursuant to the provisions of Section 607.1006, Florida Statutes, Cord Blood America, Inc., a Florida corporation (the “Corporation”), adopts the following articles of amendment to its Amended and Restated Articles of Incorporation:
Upon the filing and effectiveness of these Articles of Amendment to the Amended And Restated Articles of Incorporation with the Florida Secretary of State, the existing first paragraph of Article II of the Amended And Restated Articles of Incorporation shall be amended to read as follows:
“The total number of shares of Capital Stock which this corporation shall have the authority to issue is TWO HUNDRED, FIFTY-FIVE MILLION ( 255,000,000 ) shares, consisting of Five Million (5,000,000) shares of Preferred Stock having a par value of $0.0001 per share and TWO HUNDRED, FIFTY MILLION (250,000,000) shares of Common Stock having a par value of $0.0001 per share. “
A-1
--------------------------------------------------------------------------------
PROXY
CORD BLOOD AMERICA, INC.
SPECIAL MEETING OF STOCKHOLDERS - TO BE HELD ON
April 21, 2011
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
The undersigned, revoking all prior proxies, hereby appoints Matthew Schissler with full power of substitution in each, as proxies for the undersigned, to represent the undersigned and to vote all the shares of Common Stock of the Company which the undersigned would be entitled to vote, as fully as the undersigned could vote and act if personally present, at the Special Meeting of Stockholders (the " Meeting ") to be held on or about April 21, 2011, at 10:00 a.m., Pacific Standard Time, at Helm Drive, Las Vegas, NV 89119, or at any adjournments or postponements thereof.
Should the undersigned be present and elect to vote at the Meeting or at any adjournments or postponements thereof, and after notification to the Secretary of the Company at the Meeting of the stockholder's decision to terminate this proxy, then the power of such attorneys or proxies shall be deemed terminated and of no further force and effect. This proxy may also be revoked by filing a written notice of revocation with the Secretary of the Company or by duly executing a proxy bearing a later date.
THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR" IN SUPPORT OF THE LISTED PROPOSALS SET FORTH BELOW, WHICH ARE PROPOSED BY THE COMPANY
1. Proposal to amend the Company’s Amended and Restated Articles of Incorporation to give effect to a Reverse Stock split of the Company’s outstanding Common stock, on a one reverse split common share for each 100 existing common shares.
o For o Against o Abstain
2. . (to be adopted only if Proposal 1 is adopted.) Proposal to amend the Company’s Amended and Restated Articles of Incorporation to fix the authorized Capital Stock of the Company at 255,000,000 Capital shares, of which 5,000,000 Shares shall be Preferred Shares, and 250,000,000 shares shall be Common Shares.
o For o Against o Abstain
3. In their discretion, the Proxies are authorized to vote upon such other business as may properly come before the meeting or any adjournment or adjournments thereof.
o For o Against o Abstain
The shares represented by this proxy will be voted as directed by the stockholder, but if no instructions are specified, this proxy will be voted for proposal (1), and if proposal (1) is adopted, this proxy will be voted for proposal (2).. If any other business is presented at the Meeting, this proxy will be voted by those named in this proxy in their best judgment. At the present time, the board of directors knows of no other business to be presented at the Meeting.
The undersigned acknowledges receipt from the Company, prior to the execution of this proxy, of the Notice of Special Meeting and accompanying Proxy Statement relating to the Meeting.
NOTE: PLEASE MARK, DATE AND SIGN AS YOUR NAME(S) APPEAR(S) HEREON AND RETURN IN THE ENCLOSED ENVELOPE. IF ACTING AS AN EXECUTOR, ADMINISTRATOR, TRUSTEE, GUARDIAN, ETC., YOU SHOULD SO INDICATE WHEN SIGNING. IF THE SIGNER IS A CORPORATION, PLEASE SIGN THE FULL CORPORATE NAME, BY A DULY AUTHORIZED OFFICER. IF SHARES ARE HELD JOINTLY, EACH SHAREHOLDER SHOULD SIGN.
Signature (Please sign within the box)
Date:_______ 2011
Signature (Joint owners) Date:_______ 2011 _
How Can I Vote Without Attending the Special Meeting?
There are three convenient methods for registered stockholders to direct their vote by proxy without attending the Special Meeting:
● Submit your proxy by Internet. You can submit your proxy via the Internet. The website address for Internet voting is provided on your Cord Blood Notice or proxy card. You will need to use the control number appearing on your Cord Blood Notice or proxy card to vote via the Internet. You can use the Internet to transmit your voting instructions up until 11:59 P.M. Eastern Time on April 20, 2011. Internet voting is available 24 hours a day. If you submit your proxy via the Internet you do NOT need to submit a proxy by telephone or return a proxy card.
● Vote by Telephone. You may also be able to submit your proxy by telephone by calling the toll-free telephone number provided on your Cord Blood proxy card. You will need to use the control number appearing on your Cord Blood proxy card to submit your proxy by telephone. You may transmit your voting instructions from any touch-tone telephone up until 11:59 P.M. Eastern Time on April 20, 2011. Telephone voting is available 24 hours a day. If you submit your proxyby telephone you do NOT need to submit a proxy over the Internet or return a proxy card.
● Vote by Mail. You can submit your proxy by marking, dating and signing the enclosed Proxy Card Form, and returning it in the postage-paid envelope provided. Please promptly mail your proxy card to ensure that it is received prior to the closing of the polls at the Special Meeting.
Proxies should not be sent by the stockholder to the Company, but please use pre-addressed, postage-paid envelope is provided for this purpose.
If you are a beneficial owner, or you hold your shares in "street name," please check your voting instruction card or contact your bank, broker or nominee to determine whether you will be able to vote by Internet or telephone.
EXHIBIT A
PROPOSAL 1:
TO REVERSE SPLIT THE OUTSTANDING COMMON STOCK OF CORD BLOOD AMERICA, INC. ON THE BASIS OF ONE NEW POST SPLIT COMMON SHARE FOR EACH 100 CURRENTLY OUTSTANDING COMMON SHARES
Pursuant to the provisions of Section 607.1006, Florida Statutes, Cord Blood America, Inc., a Florida corporation (the “Corporation”), adopts the following articles of amendment to its Amended and Restated Articles of Incorporation:
The Amended and Restated Articles of Incorporation of the Corporation are hereby amended as follows:
“Upon the filing and effectiveness of this Amendment to the Amended and Restated Articles of Incorporation with the Florida Secretary of State, every ONE HUNDRED ( 100 ) outstanding shares of Common Stock shall be automatically combined into one (1) share of Common Stock.”
PROPOSAL 2:
TO AMENDMENT THE AMENDED AND RESTATE ARTICLES OF CORD BLOOD AMERICA, INC., TO FIX THE AUTHORIZED CAPITAL STOCK AT 255,000,000 CAPITAL SHARES
Pursuant to the provisions of Section 607.1006, Florida Statutes, Cord Blood America, Inc., a Florida corporation (the “Corporation”), adopts the following articles of amendment to its Amended and Restated Articles of Incorporation:
Upon the filing and effectiveness of these Articles of Amendment to the Amended And Restated Articles of Incorporation with the Florida Secretary of State, the existing first paragraph of Article II of the Amended And Restated Articles of Incorporation shall be amended to read as follows:
“The total number of shares of Capital Stock which this corporation shall have the authority to issue is TWO HUNDRED, FIFTY-FIVE MILLION ( 255,000,000 ) shares, consisting of Five Million (5,000,000) shares of Preferred Stock having a par value of $0.0001 per share and TWO HUNDRED, FIFTY MILLION (250,000,000) shares of Common Stock having a par value of $0.0001 per share. “
A-1
--------------------------------------------------------------------------------
PROXY
CORD BLOOD AMERICA, INC.
SPECIAL MEETING OF STOCKHOLDERS - TO BE HELD ON
April 21, 2011
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
The undersigned, revoking all prior proxies, hereby appoints Matthew Schissler with full power of substitution in each, as proxies for the undersigned, to represent the undersigned and to vote all the shares of Common Stock of the Company which the undersigned would be entitled to vote, as fully as the undersigned could vote and act if personally present, at the Special Meeting of Stockholders (the " Meeting ") to be held on or about April 21, 2011, at 10:00 a.m., Pacific Standard Time, at Helm Drive, Las Vegas, NV 89119, or at any adjournments or postponements thereof.
Should the undersigned be present and elect to vote at the Meeting or at any adjournments or postponements thereof, and after notification to the Secretary of the Company at the Meeting of the stockholder's decision to terminate this proxy, then the power of such attorneys or proxies shall be deemed terminated and of no further force and effect. This proxy may also be revoked by filing a written notice of revocation with the Secretary of the Company or by duly executing a proxy bearing a later date.
THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR" IN SUPPORT OF THE LISTED PROPOSALS SET FORTH BELOW, WHICH ARE PROPOSED BY THE COMPANY
1. Proposal to amend the Company’s Amended and Restated Articles of Incorporation to give effect to a Reverse Stock split of the Company’s outstanding Common stock, on a one reverse split common share for each 100 existing common shares.
o For o Against o Abstain
2. . (to be adopted only if Proposal 1 is adopted.) Proposal to amend the Company’s Amended and Restated Articles of Incorporation to fix the authorized Capital Stock of the Company at 255,000,000 Capital shares, of which 5,000,000 Shares shall be Preferred Shares, and 250,000,000 shares shall be Common Shares.
o For o Against o Abstain
3. In their discretion, the Proxies are authorized to vote upon such other business as may properly come before the meeting or any adjournment or adjournments thereof.
o For o Against o Abstain
The shares represented by this proxy will be voted as directed by the stockholder, but if no instructions are specified, this proxy will be voted for proposal (1), and if proposal (1) is adopted, this proxy will be voted for proposal (2).. If any other business is presented at the Meeting, this proxy will be voted by those named in this proxy in their best judgment. At the present time, the board of directors knows of no other business to be presented at the Meeting.
The undersigned acknowledges receipt from the Company, prior to the execution of this proxy, of the Notice of Special Meeting and accompanying Proxy Statement relating to the Meeting.
NOTE: PLEASE MARK, DATE AND SIGN AS YOUR NAME(S) APPEAR(S) HEREON AND RETURN IN THE ENCLOSED ENVELOPE. IF ACTING AS AN EXECUTOR, ADMINISTRATOR, TRUSTEE, GUARDIAN, ETC., YOU SHOULD SO INDICATE WHEN SIGNING. IF THE SIGNER IS A CORPORATION, PLEASE SIGN THE FULL CORPORATE NAME, BY A DULY AUTHORIZED OFFICER. IF SHARES ARE HELD JOINTLY, EACH SHAREHOLDER SHOULD SIGN.
Signature (Please sign within the box)
Date:_______ 2011
Signature (Joint owners) Date:_______ 2011 _
für alle "neuen":
der r/s ist jetzt durchgeführt und der aktienkurs fängt an zu steigen !!! -
was eigentlich sehr selten ist.
aber dieser r/s wurde lange geplant und nicht einfach über nacht durchgeführt.
der r/s ist jetzt durchgeführt und der aktienkurs fängt an zu steigen !!! -
was eigentlich sehr selten ist.
aber dieser r/s wurde lange geplant und nicht einfach über nacht durchgeführt.
Obama darf embryonale Stammzellenforschung weiter staatlich fördern
US-Berufungsgericht kippt Entscheidung aus erster Instanz
Ein US-Berufungsgericht hat der Regierung von Präsident Barack Obama am Freitag grünes Licht für die Fortführung der staatlichen Förderung der embryonalen Stammzellenforschung gegeben. Es sei unwahrscheinlich, dass die Kläger mit ihrer Forderung nach einem Förderstopp Erfolg haben würden, hieß es in der Erklärung des Gerichts in Washington. Dieses Urteil in zweiter Instanz ist ein wichtiger Sieg für Obama, der die staatliche Förderung der Stammzellenforschung im März 2009 wieder erlaubt und damit den Kurs seines Vorgängers George W. Bush in dieser umstrittenen Frage korrigiert hatte.
Mehr zum Thema:
--------------------------------------------------------------------------------
Stammzellen Obama
Im August hatte das Gericht die Förderung in erster Instanz vorerst gestoppt und war damit dem Antrag von zwei Wissenschaftlern und christlichen Organisationen gefolgt, die die Wiedereinführung der staatlichen Förderung angefochten hatten. Sie argumentierten, ein Embryo sei bereits ein vollständiger Mensch. Der Staat dürfe keine Forschung unterstützen, die die Zerstörung des Embryos zur Folge habe, auch wenn damit andere Leben gerettet werden könnten.
Bei den embryonalen Stammzellen handelt es sich um Zellen eines menschlichen Embryos in den ersten Tagen der Entwicklung. Wissenschaftler sind überzeugt, mit diesen beschädigte oder kranke Zellen ersetzen zu können und damit Lähmungen, Blindheit und einige chronische Krankheiten heilen zu können.
29.04.2011 - 19:01 Uhr
© AFP Agence France-Presse GmbH 2010
http://www.123recht.net/article.asp?a=90560&ccheck=1
US-Berufungsgericht kippt Entscheidung aus erster Instanz
Ein US-Berufungsgericht hat der Regierung von Präsident Barack Obama am Freitag grünes Licht für die Fortführung der staatlichen Förderung der embryonalen Stammzellenforschung gegeben. Es sei unwahrscheinlich, dass die Kläger mit ihrer Forderung nach einem Förderstopp Erfolg haben würden, hieß es in der Erklärung des Gerichts in Washington. Dieses Urteil in zweiter Instanz ist ein wichtiger Sieg für Obama, der die staatliche Förderung der Stammzellenforschung im März 2009 wieder erlaubt und damit den Kurs seines Vorgängers George W. Bush in dieser umstrittenen Frage korrigiert hatte.
--------------------------------------------------------------------------------
Stammzellen Obama
Im August hatte das Gericht die Förderung in erster Instanz vorerst gestoppt und war damit dem Antrag von zwei Wissenschaftlern und christlichen Organisationen gefolgt, die die Wiedereinführung der staatlichen Förderung angefochten hatten. Sie argumentierten, ein Embryo sei bereits ein vollständiger Mensch. Der Staat dürfe keine Forschung unterstützen, die die Zerstörung des Embryos zur Folge habe, auch wenn damit andere Leben gerettet werden könnten.
Bei den embryonalen Stammzellen handelt es sich um Zellen eines menschlichen Embryos in den ersten Tagen der Entwicklung. Wissenschaftler sind überzeugt, mit diesen beschädigte oder kranke Zellen ersetzen zu können und damit Lähmungen, Blindheit und einige chronische Krankheiten heilen zu können.
29.04.2011 - 19:01 Uhr
© AFP Agence France-Presse GmbH 2010
http://www.123recht.net/article.asp?a=90560&ccheck=1
ein sattes kursplus heute !!
das sieht doch echt gut aus !!
http://www.wallstreet-online.de/aktien/11251128/kurse
das sieht doch echt gut aus !!
http://www.wallstreet-online.de/aktien/11251128/kurse
GREEN
The Key
The Chill - CBAI
Here is another example :
November 14, 2011 09:00 AM Eastern Time
Smart Holdings, Inc. (SMHS) Comments on DTCC Stock Chill
MARIETTA, Ga.--(BUSINESS WIRE)--Smart Holdings, Inc. (SMHS.PK), announced today that the Company has been aggressively trying to remove a DTC chill order placed by the DTCC back in June. The ‘chill order’ means that the Company’s stock cannot be transferred using DTC brokers, limiting them from freely trading the company stock without hurdles resulting in shareholders inability to buy or sell stock in the open market. No notice or explanation was received prior to the chill or after the chill was put in place; a move which has clearly damaged investor confidence.
The Company reported calling the DTCC numerous times and hired two different attorneys who also could not get any answers. The Company spoke to seven different representatives at the DTCC who could not give any reason or information regarding the chill order. The Company said all efforts are being made to determine the cause so they can resolve the issue.
In other news, the Company is revising its Prescription RX website with a whole new look. The recent TV and newspaper campaign produced hundreds of leads and they have hired an SEO company to help gain page ranking.
About Smart Holdings, Inc.
Headquartered in Marietta, GA, Smart Holdings, Inc., through its wholly owned subsidiary, Assurance Group Direct, is in the business of selling automotive extended service plans and health care plans on a nationwide basis. Products now being sold include Prescription Medication Savings Plan and the Dental, Vision, Hearing and Chiropractic savings plans. The company is marketing directly to consumers through national television, Internet and other mass medias including social networking.
For more information, please visit:
www.smartholdingsinc.com,
www.assurancedirectrx.com or
www.assurancegroupdirect.com
Forward Looking Statements
This press release includes statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). Smart Holdings, Inc. claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. These forward-looking statements are often characterized by the terms "may," "believes," "projects," "expects," or "anticipates," and do not reflect historical facts. Specific forward-looking statements contained in this press release include, but are not limited to: our successful integration of diversified growth companies, impact of the company's expansion plan, and new business development success, future financial results, development and acquisition of new product lines and services, the impact of competitive products or pricing from technological changes, the effect of economic conditions and other uncertainties.
Contacts
Smart Holdings, Inc.
Investor Relations, 516-482-0155
ir@smartholdingsinc.com
Recent Stories from Smart Holdings, Inc.
The Chill - CBAI
Here is another example :
November 14, 2011 09:00 AM Eastern Time
Smart Holdings, Inc. (SMHS) Comments on DTCC Stock Chill
MARIETTA, Ga.--(BUSINESS WIRE)--Smart Holdings, Inc. (SMHS.PK), announced today that the Company has been aggressively trying to remove a DTC chill order placed by the DTCC back in June. The ‘chill order’ means that the Company’s stock cannot be transferred using DTC brokers, limiting them from freely trading the company stock without hurdles resulting in shareholders inability to buy or sell stock in the open market. No notice or explanation was received prior to the chill or after the chill was put in place; a move which has clearly damaged investor confidence.
The Company reported calling the DTCC numerous times and hired two different attorneys who also could not get any answers. The Company spoke to seven different representatives at the DTCC who could not give any reason or information regarding the chill order. The Company said all efforts are being made to determine the cause so they can resolve the issue.
In other news, the Company is revising its Prescription RX website with a whole new look. The recent TV and newspaper campaign produced hundreds of leads and they have hired an SEO company to help gain page ranking.
About Smart Holdings, Inc.
Headquartered in Marietta, GA, Smart Holdings, Inc., through its wholly owned subsidiary, Assurance Group Direct, is in the business of selling automotive extended service plans and health care plans on a nationwide basis. Products now being sold include Prescription Medication Savings Plan and the Dental, Vision, Hearing and Chiropractic savings plans. The company is marketing directly to consumers through national television, Internet and other mass medias including social networking.
For more information, please visit:
www.smartholdingsinc.com,
www.assurancedirectrx.com or
www.assurancegroupdirect.com
Forward Looking Statements
This press release includes statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). Smart Holdings, Inc. claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. These forward-looking statements are often characterized by the terms "may," "believes," "projects," "expects," or "anticipates," and do not reflect historical facts. Specific forward-looking statements contained in this press release include, but are not limited to: our successful integration of diversified growth companies, impact of the company's expansion plan, and new business development success, future financial results, development and acquisition of new product lines and services, the impact of competitive products or pricing from technological changes, the effect of economic conditions and other uncertainties.
Contacts
Smart Holdings, Inc.
Investor Relations, 516-482-0155
ir@smartholdingsinc.com
Recent Stories from Smart Holdings, Inc.
Antwort auf Beitrag Nr.: 42.363.190 von gerdass am 17.11.11 13:01:26Und was bedeutet das für CBAI?
Mein Englich ist ganz schwach.
Mein Englich ist ganz schwach.
a..W ..
immer das Gleiche, wenn es runter geht, traut sich kaum Einer zu kaufen
der gestriege Handelsverlauf in den USA
Antwort auf Beitrag Nr.: 42.382.576 von gerdass am 22.11.11 11:05:24Schöner Abgang,
1 Dollar wir kommen
1 Dollar wir kommen
Antwort auf Beitrag Nr.: 42.382.875 von Scania01 am 22.11.11 12:07:06den halte auch ich für nicht unmöglich
Antwort auf Beitrag Nr.: 42.382.875 von Scania01 am 22.11.11 12:07:06In wieviel Jahren?
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Investoren beobachten auch:
Wertpapier | Perf. % |
---|---|
+1,40 | |
+3,90 | |
0,00 | |
-0,16 | |
-0,64 | |
+1,33 | |
+0,53 | |
+0,44 | |
+5,63 | |
+0,60 |
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
238 | ||
84 | ||
83 | ||
82 | ||
76 | ||
53 | ||
47 | ||
38 | ||
35 | ||
34 |